OKTA Stock Analysis: Okta | NASDAQ
Software - Infrastructure | NASDAQ, USA | Market Cap: 31.882m USD | 12M Return: 114.1% | US6792951054 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 776M
EPS Trend: 81.7%
Qual. Beats: 17
Rev. Trend: 99.6%
Qual. Beats: 17
Warnings
Tailwinds
Seasonality 9.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Okta, Inc. (NASDAQ: OKTA) is a U.S.-based identity management software company that provides cloud-delivered solutions for securing and managing user, application, and device access. Its platform spans Single Sign-On, Adaptive Multi-Factor Authentication, API Access Management, Universal Directory, and privileged access and identity governance tools, with offerings extended to securing AI agents and machine-to-machine identities. Okta generates revenue primarily through a subscription-based, Software-as-a-Service (SaaS) model, which is typical within the identity-as-a-service (IDaaS) segment of the broader cybersecurity market.
The company sells to enterprise and mid-market customers across both workforce identity (employees, contractors, and internal systems) and customer identity (external users and applications), serving organizations that operate hybrid cloud and on-premises IT environments. Oktas products are largely modular and sold on a per-user subscription basis, allowing customers to expand usage as identity and access requirements grow. The company was originally incorporated in 2009 as Saasure, Inc., is headquartered in San Francisco, California, and has been listed on NASDAQ since its April 2017 IPO.
- Subscription revenue growth accelerates with enterprise customer additions
- Microsoft Entra competition pressures identity market share gains
- Operating leverage expands margins on the path to profitability
- AI agent identity products open new addressable market
| Net Income: 296.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.86 > 1.0 |
| NWC/Revenue: 34.62% < 20% (prev 33.26%; Δ 1.36% < -1%) |
| CFO/TA 0.11 > 3% & CFO 987.0m > Net Income 296.0m |
| Net Debt (-2.25b) to EBITDA (321.0m): -7.00 < 3 |
| Current Ratio: 1.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (178.8m) vs 12m ago -1.19% < -2% |
| Gross Margin: 78.13% > 18% (prev 76.91%; Δ 1.22% > 0.5%) |
| Asset Turnover: 32.89% > 50% (prev 28.93%; Δ 3.96% > 0%) |
| Interest Coverage Ratio: 78.67 > 6 (EBIT TTM 236.0m / Interest Expense TTM 3.00m) |
| A: 0.12 (Total Current Assets 3.09b - Total Current Liabilities 2.02b) / Total Assets 9.14b |
| B: -0.26 (Retained Earnings -2.38b / Total Assets 9.14b) |
| C: 0.03 (EBIT TTM 236.0m / Avg Total Assets 9.34b) |
| D: 3.22 (Book Value of Equity 6.97b / Total Liabilities 2.17b) |
| Altman-Z'' = 3.47 = A |
| DSRI: 1.01 (Receivables 469.0m/417.0m, Revenue 3.07b/2.76b) |
| GMI: 0.98 (GM 76.91% / 78.13%) |
| AQI: 1.06 (AQ_t 0.65 / AQ_t-1 0.62) |
| SGI: 1.11 (Revenue 3.07b / 2.76b) |
| TATA: -0.08 (NI 296.0m - CFO 987.0m) / TA 9.14b) |
| Beneish M = -2.92 (Cap -4..+1) = A |
As of September 27, 2026, the stock is trading at USD 195.19 with a total of 3,972,392 shares traded. Over the past week, the price has changed by +7.03%, over one month by +49.44%, over three months by +63.67% and over the past year by +114.05%.
Current recommended Stop Loss: 170.00 (which is 12.9% or 2.6 ATR below the current price).
Okta has received a consensus analysts rating of 3.96. Therefore, it is recommended to buy OKTA.
- StrongBuy: 18
- Buy: 8
- Hold: 18
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 185.9 | -4.8% |
P/E Trailing = 109.8614
P/E Forward = 48.3092
P/S = 10.3749
P/B = 4.5722
P/EG = 1.5077
Revenue TTM = 3.07b USD
EBIT TTM = 236.0m USD
EBITDA TTM = 321.0m USD
Long Term Debt = unknown (none)
Short Term Debt = 350.0m USD (from shortTermDebt, last fiscal year)
Debt = 53.0m USD (from shortLongTermDebtTotal, last quarter) (leases 53.0m already included)
Net Debt = -2.25b USD (calculated: Debt 53.0m - CCE 2.30b)
Enterprise Value = 29.6b USD (31.9b + Debt 53.0m - CCE 2.30b)
Interest Coverage Ratio = 78.67 (Ebit TTM 236.0m / Interest Expense TTM 3.00m)
EV/FCF = 30.49x (Enterprise Value 29.6b / FCF TTM 972.0m)
FCF Yield = 3.28% (FCF TTM 972.0m / Enterprise Value 29.6b)
FCF Margin = 31.63% (FCF TTM 972.0m / Revenue TTM 3.07b)
Net Margin = 9.63% (Net Income TTM 296.0m / Revenue TTM 3.07b)
Gross Margin = 78.13% ((Revenue TTM 3.07b - Cost of Revenue TTM 672.0m) / Revenue TTM)
Gross Margin QoQ = 79.63% (prev 77.78%)
Tobins Q-Ratio = 3.24 (Enterprise Value 29.6b / Total Assets 9.14b)
Interest Expense / Debt = 5.66% (Interest Expense 3.00m / Debt 53.0m)
Taxrate = 8.64% (28.0m / 324.0m)
NOPAT = 215.6m (EBIT 236.0m * (1 - 8.64%))
Current Ratio = 1.53 (Total Current Assets 3.09b / Total Current Liabilities 2.02b)
Debt / Equity = 0.01 (Debt 53.0m / totalStockholderEquity, last quarter 6.97b)
Debt / EBITDA = -7.00 (Net Debt -2.25b / EBITDA 321.0m)
Debt / FCF = -2.31 (Net Debt -2.25b / FCF TTM 972.0m)
Total Stockholder Equity = 6.94b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.17% (Net Income 296.0m / Total Assets 9.14b)
RoE = 4.26% (Net Income TTM 296.0m / Total Stockholder Equity 6.94b)
RoCE = 3.32% (EBIT 236.0m / Capital Employed (Total Assets 9.14b - Current Liab 2.02b))
RoIC = 2.95% (NOPAT 215.6m / Invested Capital 7.31b)
WACC = 9.22% (E(31.9b)/V(31.9b) * Re(9.23%) + D(53.0m)/V(31.9b) * Rd(5.66%) * (1-Tc(0.09)))
Discount Rate = 9.23% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 72.28 | Cagr: 2.96%
[DCF] Terminal Value 75.19% ; FCFF base≈918.4m ; Y1≈1.05b ; Y5≈1.55b
[DCF] Fair Price = 134.4 (EV 20.2b - Net Debt -2.25b = Equity 22.5b / Shares 167.1m; r=9.22% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 81.70 | EPS CAGR: 32.56% | SUE: 4.0 | # QB: 17
Revenue Correlation: 99.60 | Revenue CAGR: 13.20% | SUE: 4.0 | # QB: 17
EPS current Quarter (2026-10-31): EPS=0.93 | Chg30d=+0.24% | Revisions=+11% | Analysts=41
EPS current Year (2027-01-31): EPS=3.93 | Chg30d=+2.21% | Revisions=+93% | GrowthEPS=+12.3% | GrowthRev=+10.4%
EPS next Year (2028-01-31): EPS=4.38 | Chg30d=+2.17% | Revisions=+75% | GrowthEPS=+11.4% | GrowthRev=+10.0%
[Analyst] Revisions Ratio: +66% (up=98, down=19)